TCI Wealth Advisors’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-219	Closed	-$4.12K	–	212
2023 Q1	$4.12K	Hold	219	–	–	﹤0.01%	1659
2022 Q4	$3.49K	Buy	+219	New	+$3.42K	﹤0.01%	1765
2022 Q2	–	Sell	-564	Closed	-$14K	–	2245
2022 Q1	$14K	Hold	564	–	–	﹤0.01%	860
2021 Q4	$13K	Buy	564 +125	+28%	+$2.51K	﹤0.01%	950
2021 Q3	$7K	Buy	+439	New	+$8.46K	﹤0.01%	1321
2021 Q2	–	Sell	-236	Closed	-$6K	–	2300
2021 Q1	$6K	Buy	236 +86	+57%	+$3.79K	﹤0.01%	1111
2020 Q4	$8K	Hold	150	–	–	﹤0.01%	699
2020 Q3	$6K	Sell	150 -100	-40%	-$4.32K	﹤0.01%	698
2020 Q2	$12K	Hold	250	–	–	0.01%	525
2020 Q1	$11K	Buy	250 +50	+25%	+$2.06K	0.01%	542
2019 Q4	$9K	Sell	200 -100	-33%	-$4.35K	﹤0.01%	717
2019 Q3	$11K	Sell	300 -300	-50%	-$9.1K	﹤0.01%	612
2019 Q2	$16K	Hold	600	–	–	0.01%	510
2019 Q1	$16K	Hold	600	–	–	0.01%	528
2018 Q4	$10K	Sell	600 -207	-26%	-$4.02K	0.01%	615
2018 Q3	$17K	Sell	807 -214	-21%	-$3.37K	0.01%	530
2018 Q2	$16K	Sell	1,021 -479	-32%	-$8.54K	0.01%	526
2018 Q1	$34K	Sell	1,500 -250	-14%	-$6.92K	0.02%	386
2017 Q4	$53K	Buy	1,750 +150	+9%	+$4.8K	0.02%	330
2017 Q3	$60K	Sell	1,600 -100	-6%	-$3.25K	0.03%	287
2017 Q2	$47K	Buy	1,700 +82	+5%	+$2.44K	0.02%	312
2017 Q1	$56K	Hold	1,618	–	–	0.03%	286
2016 Q4	$47K	Buy	1,618 +100	+7%	+$2.65K	0.02%	331
2016 Q3	$48K	Buy	1,518 +118	+8%	+$4K	0.03%	306
2016 Q2	$45K	Buy	1,400 +100	+8%	+$3.35K	0.03%	309
2016 Q1	$36K	Hold	1,300	–	–	0.02%	344
2015 Q4	$46K	Hold	1,300	–	–	0.03%	315
2015 Q3	$43K	Buy	1,300 +50	+4%	+$2.08K	0.03%	304
2015 Q2	$52K	Hold	1,250	–	–	0.03%	279
2015 Q1	$41K	Buy	+1,250	New	+$43K	0.03%	257